CYTOSIAL

Serial Number 79189727
Registration 5111767
709

Registration Progress

Application Filed
Apr 6, 2016
Under Examination
Approved for Publication
Oct 18, 2016
Published for Opposition
Oct 18, 2016
Registered
Jan 3, 2017

Basic Information

Serial Number
79189727
Registration Number
5111767
Filing Date
April 6, 2016
Registration Date
January 3, 2017
Published for Opposition
October 18, 2016
Cancellation Date
July 14, 2023
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
709
Status Date
Jul 14, 2023

Rights Holder

BIOXIS Pharmaceuticals

99
Address
317 Avenue Jean Jaurès
F-69007 Lyon
FR

Ownership History

CYTOSIAL BIOMEDIC (SAS)

Original Applicant
99
FR

CYTOSIAL BIOMEDIC (SAS)

Owner at Publication
99
FR

BIOXIS Pharmaceuticals

Original Registrant
99
FR

Legal Representation

Attorney
Alexander Lazouski

USPTO Deadlines

Next Deadline
544 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2017-01-03)
Due Date
January 03, 2027
Grace Period Ends
July 03, 2027

Application History

36 events
Date Code Type Description
Apr 22, 2024 INNT P TOTAL INVALIDATION PROCESSED BY THE IB
Mar 27, 2024 INTS P TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 26, 2024 INPC P INVALIDATION PROCESSED
Mar 14, 2024 INTR P TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 14, 2023 C71T O CANCELLED SECTION 71
Jan 3, 2022 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 29, 2018 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 29, 2017 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 6, 2017 FIMP P FINAL DISPOSITION PROCESSED
Apr 6, 2017 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Apr 3, 2017 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 3, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER
Oct 18, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 18, 2016 PUBO A PUBLISHED FOR OPPOSITION
Sep 28, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 9, 2016 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 8, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 7, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 7, 2016 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 30, 2016 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 30, 2016 GNFR O FINAL REFUSAL E-MAILED
Aug 30, 2016 CNFR R FINAL REFUSAL WRITTEN
Aug 26, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2016 RFNT P REFUSAL PROCESSED BY IB
Aug 25, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2016 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 25, 2016 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 9, 2016 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 9, 2016 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 9, 2016 MAFR O APPLICATION FILING RECEIPT MAILED
Aug 9, 2016 RFRR P REFUSAL PROCESSED BY MPU
Aug 8, 2016 CNRT R NON-FINAL ACTION WRITTEN
Aug 5, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2016 DOCK D ASSIGNED TO EXAMINER
Aug 4, 2016 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Additional Information

Design Mark
The mark consists of the stylized term "CYTOSIAL" with a small circle superimposed over the upper right portion of the letter "O" in the mark.
Color Claim
Color is not claimed as a feature of the mark.